Each shot would be completely personalized to the patient.

Wagner’s TLPO cancer vaccine has been tested in hundreds of patients with advanced forms of melanoma in Phase 2 clinical trials.

The most recent data presented at an academic conference showed nearly 95% of people given only the vaccine were still alive three years after starting treatment and 64% were still disease-free. Among the most advanced forms of melanoma, disease-free survival after three years for people with stage III disease was 60% in the vaccine-only group, compared to about 39% in the placebo group. Disease-free survival for those with stage IV disease was about 68% in the vaccine-only group, and zero in the placebo group.

The most common side effects were redness or pain at the injection site, fever and fatigue after the injection – similar to other vaccines that stimulate an immune response.

  • TardisBeaker@lemmy.world
    link
    fedilink
    arrow-up
    46
    arrow-down
    3
    ·
    10 months ago

    They make it sound as if this is new, but this method has been studied for decades… My dad was diagnosed with stage 4 lung cancer in Jan of 2013. He happened to get into clinical trials that basically had him “living with cancer” for 5 years. It wasn’t until the last few months that the cancer outpaced the drugs and took over, invading his brain, then it was only a matter of a very short time before the brain cancer ruptured & killed him. But prior to that, he got 5 years. The drugs he was on??? Targeted immunotherapy including a lot of mRNA vaccine therapy. (Turns out he was a guinea pig for the technology that would be used in Covid vaccines. He always hoped his clinical trials would help future patients, he just had no idea how far reaching that would really be.)

    The problem is, cancer is in essence a mutation machine, which means it quickly outpaces our ability to create the vaccines. I think we’ll get there; just going to take a while before we learn how to keep up.